Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab as maintenance therapy: a prespecified secondary analysis of the PanaMa (AIO KRK 0212) trial-Reference-Cited by-同舟云学术

Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab as maintenance therapy: a prespecified secondary analysis of the PanaMa (AIO KRK 0212) trial

Published:2023-09 Issue: Volume:190 Page:112955
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Ballhausen Alexej^ORCID,Karthaus Meinolf,Fruehauf Stefan,Graeven Ullrich^ORCID,Müller Lothar,König Alexander Otto,von Weikersthal Ludwig Fischer,Sommerhäuser Greta,Alig Annabel Helga Sophie^ORCID,Goekkurt Eray^ORCID,Meyer-Knees Johanna Wanda,Kurreck Annika^ORCID,Stahler Arndt^ORCID,Held Swantje^ORCID,Kasper Stefan^ORCID,Heinrich Kathrin^ORCID,Heinemann Volker^ORCID,Stintzing Sebastian^ORCID,Trarbach Tanja,Modest Dominik Paul

Funder

AIO Studien gGmbH

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference22 articles.

1. Does severe toxicity affect global quality of life in patients with metastatic colorectal cancer during palliative systemic treatment? A systematic review;Schuurhuizen;Ann Oncol,2017

2. Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of the National Cancer Institute of Canada Clinical Trials Group;Osoba;Eur J Cancer,2005

3. Moving beyond conventional clinical trial end-points in treatment-refractory metastatic colorectal cancer: a composite quality-of-life and symptom control end-point;Gong;Clin Ther,2017

4. Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up;Cervantes;Ann Oncol,2023

5. Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials;Arnold;Ann Oncol,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dermatology-related quality-of-life outcomes in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab (Pmab) maintenance after FOLFOX + Pmab induction: a prespecified secondary analysis of the phase II randomized PanaMa (AIO KRK 0212) trial;ESMO Open;2024-07

2. Impact of Systemic Treatments on Outcomes and Quality of Life in Patients with RAS-Positive Stage IV Colorectal Cancer: A Systematic Review;Diseases;2024-04-20

3. Impacts of systemic treatments on health-related quality of life for patients with metastatic colorectal cancer: a systematic review and network meta-analysis;BMC Cancer;2024-02-09